Nivolumab vs Ondansetron
Nivolumab vs Ondansetron: Overview
This comparison examines the pharmacological differences between Nivolumab and Ondansetron.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Ondansetron: Selective 5-HT3 receptor antagonist.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Ondansetron β 3-5 hours.
Chemical Properties
Molecular Formula: Ondansetron β C18H19N3O.
Molecular Weight: Ondansetron β 293.3660 g/mol.
Type: Nivolumab β Antibody; Ondansetron β Small molecule.